Gavin Bennett

Company: Bicycle Therapeutics

Job title: Senior Director - Drug Development

Seminars:

Bicycle Conjugates to Target Solid Tumours 4:30 pm

Bicycles, constrained bicyclic peptides, offer antibody-like affinity and selectivity in a small molecule format Bicycle Toxin Conjugates are now in clinical development, offering rapid tumour penetration with limited plasma exposure Discover how Bicycles can be used to stimulate Immuno-oncology targets such as CD137, which can be targeted to tumour cells using Bicycle tumour-targeted immune cell…Read more

day: Day Two